Nuclear Pore QA

A known membrane-remodeling complex earns a newly identified role as a quality-assurance director during the assembly of nuclear pores.

Written byKerry Grens
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

DETENTION: In yeast, malformed nuclear pore complexes (red) are separated from properly built complexes (green) and not passed on to daughter cells.BRANT WEBSTER

The paper B.M. Webster et al., “Surveillance of nuclear pore complex assembly by ESCRT-III/Vps4,” Cell, 159:388–401, 2014. The construction Building the nuclear pore complex—gatekeeper to the genome—is no small feat for a cell; hundreds of proteins assemble to traffic content between the nucleus and the cytoplasm. To Patrick Lusk, a cell biologist at Yale University, it seemed likely that the assembly process, albeit essential, might fail on occasion. So his group set out to find whether there are any quality-assurance mechanisms to keep the assembly in order. The surveillance Conducting genetic assays in yeast, Lusk’s group identified the ESCRT-III complex as responsible for monitoring nuclear pore assembly and clearing malformed complexes. ESCRTs are known to bend membranes and assist in endocytosis and cytokinesis, so it’s ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • kerry grens

    Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, and the health and science reporter at New Hampshire Public Radio. Kerry got her start in journalism as a AAAS Mass Media fellow at KUNC in Colorado. She has a master’s in biological sciences from Stanford University and a biology degree from Loyola University Chicago.

    View Full Profile

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies